BALLARD PARTNERS

Lobbying for SWISS ROCKETS AG · Biotech

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · $50,000.00 income · posted Jul 16, 2026

Lobbying activity 1

Health Issues

Federal review of Company's acquisition of a Genome Sequencing company.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem